Effect of endotoxin on heart rate dynamics in rats with cirrhosis

Autonomic Neuroscience: Basic and Clinical

Volumn 177, Issue 2, 2013, Pages 104-113

  Haddadian, Zahra ^a   Eftekhari, Golnar ^a   Mazloom, Roham ^a   Jazaeri, Farahnaz ^b   Dehpour, Ahmad R ^b,c   Mani, Ali R ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cirrhosis; Endotoxin tolerance; Fractal; Heart rate variability; Rat; Telemetry

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; CHOLINERGIC STIMULATION; CHRONOTROPISM; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTOXEMIA; EXPERIMENTAL MODEL; HEART ATRIUM; HEART RATE VARIABILITY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINUS NODE; TACHYCARDIA; TELEMETRY;

BDL; BILE DUCT LIGATED; CIRRHOSIS; DETRENDED FLUCTUATION ANALYSIS; DFA; ENDOTOXIN TOLERANCE; FRACTAL; HEART RATE VARIABILITY; HRV; IL-6; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LPS; RAT; SHAM; SHAM-OPERATED; SOCS1; SUPPRESSOR OF CYTOKINE SIGNALING-1; TELEMETRY; TGF-Β; TRANSFORMING GROWTH FACTOR-BETA;

ANIMALS; ENDOTOXINS; FIBROSIS; HEART RATE; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS, BILIARY; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84883779423     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2013.02.022     Document Type: Article

References (38)

1. Ahmad S., Ramsay T., Huebsch L., Flanagan S., McDiarmid S., Batkin I., McIntyre L., Sundaresan S.R., Maziak D.E., Shamji F.M., Hebert P., Fergusson D., Tinmouth A., Seely A.J. Continuous multi-parameter heart rate variability analysis heralds onset of sepsis in adults. PLoS One 2009, 4:e6642.
2. Aronson D., Mittleman M.A., Burger A.J. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J. Cardiovasc. Electrophysiol. 2001, 12:294-300.
3. Ates F., Topal E., Kosar F., Karincaoglu M., Yildirim B., Aksoy Y., Aladag M., Harputluoglu M.M., Demirel U., Alan H., Hilmioglu F. The relationship of heart rate variability with severity and prognosis of cirrhosis. Dig. Dis. Sci. 1996, 51:1614-1618.
4. Beutler B. SHIP, TGF-beta, and endotoxin tolerance. Immunity 2004, 21:134-135.
5. Biswas S.K., Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009, 30:475-487.
6. Buchman T.G. The community of the self. Nature 2002, 420:246-251.
7. Draisma A., Pickkers P., Bouw M.P., van der Hoeven J.G. Development of endotoxin tolerance in humans in vivo. Crit. Care Med. 2009, 37:1261-1267.
8. Ebrahimkhani M.R., Kiani S., Oakley F., Kendall T., Shariftabrizi A., Tavangar S.M., Moezi L., Payabvash S., Karoon A., Hoseininik H., Mann D.A., Moore K.P., Mani A.R., Dehpour A.R. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut 2006, 55:1606-1616.
9. Eftekhari G, Ahmdai Soleimani M, Mani AR., (in press). Heart rate variability, vagal activity and the pulse of inflammation. J. Intern. Med. http://dx.doi.org/10.1111/joim.12046.
10. Gholami M., Mazaheri P., Mohamadi A., Dehpour T., Safari F., Hajizadeh S., Moore K.P., Mani A.R. Endotoxemia is associated with partial uncoupling of cardiac pacemaker from cholinergic neural control in rats. Shock 2012, 37:219-227.
11. Godin P.J., Fleisher L.A., Eidsath A., Vandivier R.W., Preas H.L., Banks S.M., Buchman T.G., Suffredini A.F. Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. Crit. Care Med. 1996, 24:1117-1124.
12. Goldberger A.L., Amaral L.A., Hausdorff J.M., Ivanov P.Ch., Peng C.K., Stanley H.E. Fractal dynamics in physiology: alterations with disease and aging. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(Suppl. 1):2466-2472.
13. Goldstein B., Fiser D.H., Kelly M.M., Mickelsen D., Ruttimann U., Pollack M.M. Decomplexification in critical illness and injury: relationship between heart rate variability, severity of illness, and outcome. Crit. Care Med. 1998, 26:352-357.
14. González-Clemente J.M., Vilardell C., Broch M., Megia A., Caixàs A., Giménez-Palop O., Richart C., Simón I., Martínez-Riquelme A., Arroyo J., Mauricio D., Vendrell J. Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes. Eur. J. Endocrinol. 2007, 157:31-38.
15. Hajiasgharzadeh K., Mirnajafi-Zadeh J., Mani A.R. Interleukin-6 impairs chronotropic responsiveness to cholinergic stimulation and decreases heart rate variability in mice. Eur. J. Pharmacol. 2011, 673:70-77.
16. Harry D., Anand R., Holt S., Davies S., Marley R., Fernando B., Goodier D., Moore K. Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rat. Hepatology 1999, 30:1198-1205.
17. Hendrickse M.T., Thuluvath P.J., Triger D.R. Natural history of autonomic neuropathy in chronic liver disease. Lancet 1992, 339:1462-1464.
18. Ivanov P.C., Amaral L.A., Goldberger A.L., Havlin S., Rosenblum M.G., Struzik Z.R., Stanley H.E. Multifractality in human heartbeat dynamics. Nature 1999, 399:461-465.
19. Jazaeri F., Tavangar S.M., Ghazi-Khansari M., Khorramizadeh M.R., Mani A.R., Dehpour A.R. Cirrhosis is associated with development of tolerance to cardiac chronotropic effect of endotoxin in rats. Liver Int. 2013, 33:368-374.
20. Kox M., Pompe J.C., van der Hoeven J.G., Hoedemaekers C.W., Pickkers P. Influence of different breathing patterns on heart rate variability indices and reproducibility during experimental endotoxaemia in human subjects. Clin. Sci. (Lond.) 2011, 121:215-222.
21. Lake D.E., Richman J.S., Griffin M.P., Moorman J.R. Sample entropy analysis of neonatal heart rate variability. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 2:R789-R797.
22. Mani A.R., Ippolito S., Ollosson R., Moore K.P. Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis. Hepatology 2006, 43:847-856.
23. Mani A.R., Montagnese S., Jackson C.D., Jenkins C.W., Head I.M., Stephens R.C., Moore K.P., Morgan M.Y. Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G330-G338.
24. Niskanen J.P., Tarvainen M.P., Ranta-Aho P.O., Karjalainen P.A. Software for advanced HRV analysis. Comput. Methods Programs Biomed. 2004, 76:73-81.
25. O'Brien A.J., Welch C.A., Singer M., Harrison D.A. Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients. Intensive Care Med. 2012, 38:991-1000.
26. Ottesen L.H., Harry D., Frost M., Davies S., Khan K., Halliwell B., Moore K. Increased formation of S-nitrosothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic. Biol. Med. 2001, 31:790-798.
27. Peng C.K., Havlin S., Stanley H.E., Goldberger A.L. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos 1995, 5:82-87.
28. Piao W., Song C., Chen H., Diaz M.A., Wahl L.M., Fitzgerald K.A., Li L., Medvedev A.E. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J. Leukoc. Biol. 2009, 86:863-875.
29. Pincus S.M. Greater signal regularity may indicate increased system isolation. Math. Biosci. 1994, 122:161-181.
30. Scott M.J., Liu S., Shapiro R.A., Vodovotz Y., Billiar T.R. Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism. Hepatology 2009, 49:1695-1708.
31. Sly L.M., Rauh M.J., Kalesnikoff J., Song C.H., Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 2004, 21:227-239.
32. Tateishi Y., Oda S., Nakamura M., Watanabe K., Kuwaki T., Moriguchi T., Hirasawa H. Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients. Shock 2007, 28:549-553.
33. Thalheimer U., Burroughs A.K. Bacterial translocation and cardiovascular complications of cirrhosis. Gut 2008, 57:1181-1182.
34. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 2007, 117:289-296.
35. Tritto G., Bechlis Z., Stadlbauer V., Davies N., Francés R., Shah N., Mookerjee R.P., Such J., Jalan R. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J. Hepatol. 2011, 55:574-581.
36. Tulppo M.P., Makikallio T.H., Takala T.E., Seppanen T., Huikuri H.V. Quantitative beat-to-beat analysis of heart rate dynamics during exercise. Am. J. Physiol. Heart Circ. Physiol. 1996, 271:H244-H252.
37. Wong F., Bernardi M., Balk R., Christman B., Moreau R., Garcia-Tsao G., Patch D., Soriano G., Hoefs J., Navasa M. International Ascites Club. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005, 54:718-725.
38. Wright G., Davies N.A., Shawcross D.L., Hodges S.J., Zwingmann C., Brooks H.F., Mani A.R., Harry D., Stadlbauer V., Zou Z., Williams R., Davies C., Moore K.P., Jalan R. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology 2007, 45:1517-1526.